Company / CapEx per Share
Nurix Therapeutics, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.18
FY2025
5-year range
$0.04 / $0.19
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
#44 of 192
Health Care
What the data says
Nurix Therapeutics, Inc.'s capex per share of $0.18 is higher than 77% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 7 years, ranging from $0.04 in FY2021 to $1.27 in FY2020.
Based on SEC 10-K filings.
0.18 in FY2025 with a 5-year CAGR of -32.0%. Top quartile in the Health Care sector.
Improved from $0.18 to $0.18 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- -32.0%
- 10-Year CAGR
- -
Sector benchmark
-92.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 3.0% year-over-year.
- Ranks #44 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.18 | -3.0% |
| FY2024 | $0.19 | +6.9% |
| FY2023 | $0.18 | +40.5% |
| FY2022 | $0.13 | +198.4% |
| FY2021 | $0.04 | -96.6% |
| FY2020 | $1.27 | +152.5% |
| FY2019 | $0.50 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026